Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by tuesdaynightridon Jul 15, 2014 5:43pm
143 Views
Post# 22748384

RE:RE:NIH: 8M$ to Penn State - Study Effects of PDT on Lung Cancer

RE:RE:NIH: 8M$ to Penn State - Study Effects of PDT on Lung Cancerbencro,

Another excellent job of resurrecting past trials related to TLT activity.

Some excerpts:
(1)  For patients with deadly cancer, the team injects Photofrin intravenously one day and takes the person to OR the next day. Photofrin is absorbed instantly by all cells of the body but it concentrates in cancer cells.
(2) The Photofrin in the cancer cells is activated by laser light and, in pretense of oxygen, triggers cell death.

So let's summarize:
- Photofrin is absorbed by all cells but is concentrated in cancer cells. The TLT PDC is hundreds of times more potent tha either ALA or Photofrin
- "in the presence of oxygen, triggers cell death". There's that O2 molecule again which does not have any negative impact on health cells which are normally oxygenated but when O2 is activated at the cancer cell nucleus the the result is cell death

Listen people. I know this is starting to sound redundant but these separate trials by others are reaching much the same conclusion.

Bullboard Posts